Using online surveys to measure level of patient symptoms and seeing how regularly monitoring that impacts a patient's healthcare experience.

The purpose of this study is to create a biobank by collecting and storing specimens, such as blood and tissue, along with medical information such as demographics and treatment, from a large group of patients with pancreatic tumors. This biobank can then be used by future studies focused on pancreatic tumors.

For more information, please visit our website: https://cecs.unc.edu The purpose of this research study is to learn more about the diagnosis, treatment, and survivorship experiences of adults with endometrial cancer. Initial enrollment goals are for 1,800 adults living in North Carolina at the time of their recent first diagnosis of endometrial cancer. This project will provide important data for integrating tumor biology, access to care, and other factors to identify contributors, and potential areas for intervention to address endometrial cancer disparities. Study staff will pursue annual follow-ups with participants, requesting updates to treatment status and quality of life measures for approximately 5yrs.

We will identify changes in the numbers, seriousness, and outcomes of breast cancers diagnosed during the COVID-19 pandemic, compared to before the pandemic.

The purpose of the study is to address the lack of sufficient observational data related to lymphoma in Malawi and therefore by doing this to serve as a foundation for developing optimal treatment strategies that would be of more benefits in the treatment of Children, Adolescent and young adults with Burkitt lymphoma.

The purpose of this research study is to assess the patient-level, healthcare provider/system-level, and community-level barriers to resolving abnormal mammograms and initiation of treatment of breast cancer in the 3 geographic regions of North Carolina: the greater Charlotte area, the Northwest, and the Northeast. These areas include the following counties: Anson, Cabarrus, Cleveland, Gaston, Lincoln, Mecklenburg, Stanly, Union, Edgecombe, Halifax, Nash, Northampton, Wilson , Ashe, Alleghany, Surry, Stokes, Watauga, Wilkes, Yadkin, Forsyth, Avery, Caldwell, Alexander, Iredell, Davie, Davidson, Burke, Catawba, and Rowan. These barriers can include obtainment of biopsies and other diagnostic procedures for resolving abnormal mammograms abnormalities or breast symptoms, access to care providers after breast cancer diagnosis, and initiation of appropriate surgical, chemotherapy, and radiation treatments after diagnosis.

This project is a randomized clinical trial (study that randomly assigns participants to one arm to fairly understand outcomes) that aims to assess if information from gene expression classifier (GEC) testing is helpful for both patients and their doctors in the management of care for newly diagnosed prostate cancer patients.

This study will evaluate the safety and tolerability of EG 70, a gene therapy, which is given inside the bladder, and its effectiveness on eliminating bladder tumors in patients with NMIBC who have failed BCG therapy and have been recommended to have their bladder removed. Giving the study drug inside the bladder is to expose cells in the lining of the bladder, including your cancerous cells, to genes that may cause an immune response inside the bladder and kill the tumor cells.

The purpose of this study is to create an educational video on colorectal cancer, screening and prevention, and clinical trials in Spanish in order to demonstrate a correlation between increased education and increased willingness to participate in clinical trials in the Latinx populations through local churches.

The goal of this study is to look into the patient-reported and functional outcomes of patients who have undergone total femoral replacement or osseointegrated amputation for oncologic and traumatic indications. We want to see if functional and patient-reported outcomes are correlated and if patient satisfaction with the implants differs between surgical indications.